Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln
Nov 15 (Reuters) - Bio Vitos Pharma AB BIOVIT.ST :
* Q3 OPERATING INCOME AMOUNTED TO SEK 5,000 (103,082)
* Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -3,0 MILLION
(-3,4)
Source text: ID:nWkr34lPps
Further company coverage: BIOVIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln